These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30714095)

  • 1. Familywise error control in multi-armed response-adaptive trials.
    Robertson DS; Wason JMS
    Biometrics; 2019 Sep; 75(3):885-894. PubMed ID: 30714095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familywise error rate control for block response-adaptive randomization.
    Glimm E; Robertson DS
    Stat Methods Med Res; 2023 Jun; 32(6):1193-1202. PubMed ID: 37021480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familywise error control in multi-armed response-adaptive two-stage designs.
    Gutjahr G; Posch M; Brannath W
    J Biopharm Stat; 2011 Jul; 21(4):818-30. PubMed ID: 21516571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative models and randomization techniques for Bayesian response-adaptive randomization with binary outcomes.
    Proper J; Connett J; Murray T
    Clin Trials; 2021 Aug; 18(4):417-426. PubMed ID: 33926267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A group sequential, response-adaptive design for randomized clinical trials.
    Karrison TG; Huo D; Chappell R
    Control Clin Trials; 2003 Oct; 24(5):506-22. PubMed ID: 14500050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of methods for control allocation in multiple arm studies using response adaptive randomization.
    Viele K; Broglio K; McGlothlin A; Saville BR
    Clin Trials; 2020 Feb; 17(1):52-60. PubMed ID: 31630567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simulation study for comparing testing statistics in response-adaptive randomization.
    Gu X; Lee JJ
    BMC Med Res Methodol; 2010 Jun; 10():48. PubMed ID: 20525382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simulation study of outcome adaptive randomization in multi-arm clinical trials.
    Wathen JK; Thall PF
    Clin Trials; 2017 Oct; 14(5):432-440. PubMed ID: 28982263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials.
    Lin J; Bunn V
    Contemp Clin Trials; 2017 Mar; 54():48-59. PubMed ID: 28089763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A response-adaptive randomization procedure for multi-armed clinical trials with normally distributed outcomes.
    Williamson SF; Villar SS
    Biometrics; 2020 Mar; 76(1):197-209. PubMed ID: 31322732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A note on familywise error rate for a primary and secondary endpoint.
    Proschan MA; Follmann DA
    Biometrics; 2023 Jun; 79(2):1114-1118. PubMed ID: 35355244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Bayesian Design of Adaptive Clinical Trials.
    Giovagnoli A
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33435249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian adaptive bandit-based designs using the Gittins index for multi-armed trials with normally distributed endpoints.
    Smith AL; Villar SS
    J Appl Stat; 2018; 45(6):1052-1076. PubMed ID: 29551849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-randomization tests in clinical trials.
    Proschan MA; Dodd LE
    Stat Med; 2019 May; 38(12):2292-2302. PubMed ID: 30672002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework.
    Blenkinsop A; Parmar MK; Choodari-Oskooei B
    Clin Trials; 2019 Apr; 16(2):132-141. PubMed ID: 30648428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding new experimental arms to randomised clinical trials: Impact on error rates.
    Choodari-Oskooei B; Bratton DJ; Gannon MR; Meade AM; Sydes MR; Parmar MK
    Clin Trials; 2020 Jun; 17(3):273-284. PubMed ID: 32063029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bayesian response-adaptive trial in tuberculosis: The endTB trial.
    Cellamare M; Ventz S; Baudin E; Mitnick CD; Trippa L
    Clin Trials; 2017 Feb; 14(1):17-28. PubMed ID: 27559021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unbiased estimation for response adaptive clinical trials.
    Bowden J; Trippa L
    Stat Methods Med Res; 2017 Oct; 26(5):2376-2388. PubMed ID: 26265771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Goldilocks Design with strict type I error control in confirmatory clinical trials.
    Zhan T; Zhang H; Hartford A; Mukhopadhyay S
    J Biopharm Stat; 2020 Sep; 30(5):821-833. PubMed ID: 32297825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urn models for response-adaptive randomized designs: a simulation study based on a non-adaptive randomized trial.
    Ghiglietti A; Scarale MG; Miceli R; Ieva F; Mariani L; Gavazzi C; Paganoni AM; Edefonti V
    J Biopharm Stat; 2018; 28(6):1203-1215. PubMed ID: 29565749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.